Training: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{CMG}}; {{AE}}{{MIR}} | {{CMG}}; {{AE}}{{MIR}} | ||
== | |||
==Overview== | |||
==Pathophysiology== | |||
Write a statement here.<ref name="pmid24357736">{{cite journal| author=Nanavaty P, Alvarez MS, Alberts WM| title=Lung cancer screening: advantages, controversies, and applications. | journal=Cancer Control | year= 2014 | volume= 21 | issue= 1 | pages= 9-14 | pmid=24357736 | doi=10.1177/107327481402100102 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24357736 }} </ref> | |||
==References== | |||
{{Reflist|2}} | |||
Latest revision as of 13:55, 12 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
Pathophysiology
Write a statement here.[1]
References
- ↑ Nanavaty P, Alvarez MS, Alberts WM (2014). "Lung cancer screening: advantages, controversies, and applications". Cancer Control. 21 (1): 9–14. doi:10.1177/107327481402100102. PMID 24357736.